322 related articles for article (PubMed ID: 10203785)
1. PTEN: a tumour suppressor that functions as a phospholipid phosphatase.
Maehama T; Dixon JE
Trends Cell Biol; 1999 Apr; 9(4):125-8. PubMed ID: 10203785
[TBL] [Abstract][Full Text] [Related]
2. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
[TBL] [Abstract][Full Text] [Related]
3. The tumour suppressor PTEN: involvement of a tumour suppressor candidate protein in PTEN turnover.
Maehama T; Okahara F; Kanaho Y
Biochem Soc Trans; 2004 Apr; 32(Pt 2):343-7. PubMed ID: 15046605
[TBL] [Abstract][Full Text] [Related]
4. Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.
Leslie NR; Bennett D; Gray A; Pass I; Hoang-Xuan K; Downes CP
Biochem J; 2001 Jul; 357(Pt 2):427-35. PubMed ID: 11439092
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC.
Haas-Kogan D; Shalev N; Wong M; Mills G; Yount G; Stokoe D
Curr Biol; 1998 Oct; 8(21):1195-8. PubMed ID: 9799739
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN.
Downes CP; Bennett D; McConnachie G; Leslie NR; Pass I; MacPhee C; Patel L; Gray A
Biochem Soc Trans; 2001 Nov; 29(Pt 6):846-51. PubMed ID: 11709086
[TBL] [Abstract][Full Text] [Related]
7. PTEN 2, a Golgi-associated testis-specific homologue of the PTEN tumor suppressor lipid phosphatase.
Wu Y; Dowbenko D; Pisabarro MT; Dillard-Telm L; Koeppen H; Lasky LA
J Biol Chem; 2001 Jun; 276(24):21745-53. PubMed ID: 11279206
[TBL] [Abstract][Full Text] [Related]
8. PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies.
Dahia PL; Aguiar RC; Alberta J; Kum JB; Caron S; Sill H; Marsh DJ; Ritz J; Freedman A; Stiles C; Eng C
Hum Mol Genet; 1999 Feb; 8(2):185-93. PubMed ID: 9931326
[TBL] [Abstract][Full Text] [Related]
9. Acute regulation of the tumour suppressor phosphatase, PTEN, by anionic lipids and reactive oxygen species.
Downes CP; Walker S; McConnachie G; Lindsay Y; Batty IH; Leslie NR
Biochem Soc Trans; 2004 Apr; 32(Pt 2):338-42. PubMed ID: 15046604
[TBL] [Abstract][Full Text] [Related]
10. Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase.
Wu Y; Dowbenko D; Spencer S; Laura R; Lee J; Gu Q; Lasky LA
J Biol Chem; 2000 Jul; 275(28):21477-85. PubMed ID: 10748157
[TBL] [Abstract][Full Text] [Related]
11. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
12. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T
Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863
[TBL] [Abstract][Full Text] [Related]
13. Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN.
Gray IC; Stewart LM; Phillips SM; Hamilton JA; Gray NE; Watson GJ; Spurr NK; Snary D
Br J Cancer; 1998 Nov; 78(10):1296-300. PubMed ID: 9823969
[TBL] [Abstract][Full Text] [Related]
14. The tumor suppressor PTEN regulates T cell survival and antigen receptor signaling by acting as a phosphatidylinositol 3-phosphatase.
Wang X; Gjörloff-Wingren A; Saxena M; Pathan N; Reed JC; Mustelin T
J Immunol; 2000 Feb; 164(4):1934-9. PubMed ID: 10657643
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing of the Drosophila PTEN gene.
Smith A; Smith A; Alrubaie S; Coehlo C; Leevers SJ; Ashworth A
Biochim Biophys Acta; 1999 Oct; 1447(2-3):313-7. PubMed ID: 10542333
[TBL] [Abstract][Full Text] [Related]
16. Negative feedback regulation of the tumor suppressor PTEN by phosphoinositide-induced serine phosphorylation.
Birle D; Bottini N; Williams S; Huynh H; deBelle I; Adamson E; Mustelin T
J Immunol; 2002 Jul; 169(1):286-91. PubMed ID: 12077256
[TBL] [Abstract][Full Text] [Related]
17. The complexity of PTEN: mutation, marker and potential target for therapeutic intervention.
Steelman LS; Bertrand FE; McCubrey JA
Expert Opin Ther Targets; 2004 Dec; 8(6):537-50. PubMed ID: 15584861
[TBL] [Abstract][Full Text] [Related]
18. Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN.
Rouault JP; Kuwabara PE; Sinilnikova OM; Duret L; Thierry-Mieg D; Billaud M
Curr Biol; 1999 Mar; 9(6):329-32. PubMed ID: 10209098
[TBL] [Abstract][Full Text] [Related]
19. PTEN M-CBR3, a versatile and selective regulator of inositol 1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P5). Evidence for Ins(1,3,4,5,6)P5 as a proliferative signal.
Orchiston EA; Bennett D; Leslie NR; Clarke RG; Winward L; Downes CP; Safrany ST
J Biol Chem; 2004 Jan; 279(2):1116-22. PubMed ID: 14561749
[TBL] [Abstract][Full Text] [Related]
20. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
